The Complement System: An Important New Therapeutic Target in IgA Nephropathy
Background: IgA nephropathy is the most common primary glomerular disease worldwide, and it is an important cause of end-stage kidney disease. Until recently, there were not any treatments of proven benefit, and care of patients with IgAN primarily involved supportive measures. Within the...
Saved in:
| Main Authors: | Karshana J. Kalyanaraman, Joshua M. Thurman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2024-12-01
|
| Series: | Glomerular Diseases |
| Online Access: | https://karger.com/article/doi/10.1159/000543015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical values of serum Gd-IgA1, complement factor H and complement regulatory proteins in IgA nephropathy
by: Zou Mei, et al.
Published: (2025-05-01) -
Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case report
by: Leonore Ingold, et al.
Published: (2025-06-01) -
Carboxymethyl-lysine is a Prominent Target of Circulating IgA in IgA Nephropathy
by: Sara Alibrandi, et al.
Published: (2025-07-01) -
Relationship between renal deposition of complement C3, IgG, IgM and pathology in IgA nephropathy
by: Fang-cao Lu, et al.
Published: (2022-08-01) -
Exploring the causal effect of complement and IgA nephropathy—a Mendelian randomization study
by: Han Xu, et al.
Published: (2024-12-01)